1-147908613-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2
The NM_005267.5(GJA8):āc.658A>Gā(p.Asn220Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00326 in 1,613,986 control chromosomes in the GnomAD database, including 17 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0023 ( 1 hom., cov: 32)
Exomes š: 0.0034 ( 16 hom. )
Consequence
GJA8
NM_005267.5 missense
NM_005267.5 missense
Scores
8
7
4
Clinical Significance
Conservation
PhyloP100: 9.18
Genes affected
GJA8 (HGNC:4281): (gap junction protein alpha 8) This gene encodes a transmembrane connexin protein that is necessary for lens growth and maturation of lens fiber cells. The encoded protein is a component of gap junction channels and functions in a calcium and pH-dependent manner. Mutations in this gene have been associated with zonular pulverulent cataracts, nuclear progressive cataracts, and cataract-microcornea syndrome. [provided by RefSeq, Dec 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -18 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.20916966).
BP6
Variant 1-147908613-A-G is Benign according to our data. Variant chr1-147908613-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 217323.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-147908613-A-G is described in Lovd as [Likely_benign]. Variant chr1-147908613-A-G is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00232 (353/152110) while in subpopulation NFE AF= 0.00424 (288/67984). AF 95% confidence interval is 0.00383. There are 1 homozygotes in gnomad4. There are 150 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 16 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GJA8 | NM_005267.5 | c.658A>G | p.Asn220Asp | missense_variant | 2/2 | ENST00000369235.2 | NP_005258.2 | |
GJA8 | XM_011509417.3 | c.658A>G | p.Asn220Asp | missense_variant | 1/2 | XP_011507719.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GJA8 | ENST00000369235.2 | c.658A>G | p.Asn220Asp | missense_variant | 2/2 | 6 | NM_005267.5 | ENSP00000358238.1 |
Frequencies
GnomAD3 genomes AF: 0.00232 AC: 353AN: 151992Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
353
AN:
151992
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00229 AC: 575AN: 251474Hom.: 1 AF XY: 0.00237 AC XY: 322AN XY: 135914
GnomAD3 exomes
AF:
AC:
575
AN:
251474
Hom.:
AF XY:
AC XY:
322
AN XY:
135914
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00336 AC: 4906AN: 1461876Hom.: 16 Cov.: 35 AF XY: 0.00326 AC XY: 2371AN XY: 727244
GnomAD4 exome
AF:
AC:
4906
AN:
1461876
Hom.:
Cov.:
35
AF XY:
AC XY:
2371
AN XY:
727244
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00232 AC: 353AN: 152110Hom.: 1 Cov.: 32 AF XY: 0.00202 AC XY: 150AN XY: 74348
GnomAD4 genome
AF:
AC:
353
AN:
152110
Hom.:
Cov.:
32
AF XY:
AC XY:
150
AN XY:
74348
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
13
ALSPAC
AF:
AC:
10
ESP6500AA
AF:
AC:
4
ESP6500EA
AF:
AC:
28
ExAC
AF:
AC:
312
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 01, 2021 | This variant is associated with the following publications: (PMID: 26694549, 19182255, 28827829, 29464339) - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2024 | GJA8: BS1 - |
Cataract 1 multiple types Benign:3
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | - - |
Likely benign, criteria provided, single submitter | curation | Dept. Genetics and Cancer, Menzies Institute for Medical Research, University of Tasmania | Jan 21, 2023 | Variant identified and curated during a GJA8 specific review of the literature in relation to pediatric or congenital cataract. ACMG-AMP criteria applied: BS1, PP3. Original variant report: PMID:28827829;29464339. The cataract phenotype reported for this variant is: Nuclear and cortical. Additional phenotype/s reported in these individual/s are: aphakic glaucoma. Proband reported with this variant has no cataract; Microphthalmia, coloboma, retrobulbar cysts, microcephaly associated with normal development, reduced growth. Gene review and curation guidelines are outlined in: https://doi.org/10.1080/17469899.2023.2160320 - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Cataract 1 multiple types;C2675897:Chromosome 1q21.1 deletion syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Sep 02, 2021 | - - |
GJA8-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 17, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Zonular Pulverulent Cataract Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Developmental cataract Benign:1
Benign, no assertion criteria provided | research | Eye Genetics Research Group, Children's Medical Research Institute | Jan 09, 2015 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Pathogenic
D
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T
M_CAP
Pathogenic
D
MetaRNN
Benign
T
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
H
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Pathogenic
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at